Remedium
Remedium is a biotech company in Boston, United States, founded in 2020. It has raised $12.6M across 3 rounds, most recently a $10.0M Series A in August 2026.
We believe that any disease can be cured.
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2020
- Website
- remedium-bio.com
- Total Funding
- $12.6M
- Last Round
- $10.0M Series AAug 2026
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.
About
Remedium Bio is a gene therapy company founded in 2020 by CEO Frank Luppino and CTO Alex Goraltchouk, developing treatments for diseases with large unmet clinical need. Its proprietary Prometheus platform is designed to enable safe, durable, and dose-adjustable delivery of therapeutic genes via a single subcutaneous injection, aiming to replace repeat-dosed biologic treatments at a fraction of the cost and without genetic integration. The company's lead program is a disease-modifying gene therapy for osteoarthritis built on what it describes as the only clinically validated chondro-regenerative mechanism, and its pipeline extends into weight loss, type 2 diabetes, stroke, immunology, and neurology. Remedium is based at Lilly Gateway Labs in Boston as part of Eli Lilly's Catalyze360 program, and in September 2025 it entered a multi-target R&D collaboration with Eli Lilly to develop gene therapies for obesity and type 2 diabetes. In August 2026 the company announced the initial close of a $10 million Series A financing led by Lifespan Vision Ventures, with continued participation from Eli Lilly and HKX Capital, to advance lead programs toward first-in-human studies.
Summary
It lists 11–50 employees. It has raised $12.6M in total across 3 rounds, most recently a $10.0M Series A round in Aug 2026. Investors include Lifespan Vision Ventures and Eli Lilly.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2026
Sign up to see all 3 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/remedium"><img src="https://indexed.vc/api/badge/company/remedium" alt="Remedium on Indexed.vc" width="260" height="76" /></a>
